(SMMV) iShares MSCI USA Small-Cap - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46435G4331
SMMV: Small-Cap, Low Volatility, U.S. Equity, Investment Fund
The iShares MSCI USA Small-Cap Min Vol Factor ETF (BATS:SMMV) is designed to track the performance of small-cap US equities with lower volatility characteristics. By investing at least 80% of its assets in the underlying indexs component securities or similar investments, the fund aims to provide a relatively stable exposure to the US small-cap market.
The underlying index, developed by MSCI Inc, focuses on small-cap US stocks with aggregate lower volatility profiles compared to the broader small-cap US equity market. This approach is likely to appeal to investors seeking to mitigate potential downsides while still participating in the US small-cap markets growth potential.
Analyzing the funds recent price action, we observe a steady uptrend, as indicated by its last price of $41.50, surpassing both its 20-day and 50-day simple moving averages (SMA20: $40.83, SMA50: $40.82). The 200-day simple moving average (SMA200: $40.91) also suggests a longer-term bullish trend. The Average True Range (ATR: 0.79) translates to a daily volatility of approximately 1.90%, which is relatively moderate.
Given the current technical setup and the funds underlying strategy, we can forecast a potential price target. If the uptrend continues, the next resistance level is likely to be around the 52-week high of $43.87. Conversely, a decline is likely to find support near the SMA200 or the lower end of its recent trading range. Fundamental data, such as the funds Assets Under Management (AUM: $300.05M USD), indicates a reasonable level of investor interest, which could contribute to liquidity and stability.
Combining technical and fundamental insights, a plausible forecast for SMMV is a continued gradual appreciation, potentially reaching or testing the 52-week high in the near term, assuming the overall market sentiment remains favorable and volatility remains relatively low. However, its crucial to monitor the funds tracking performance, changes in the underlying index, and broader market conditions to adjust this forecast accordingly.
Additional Sources for SMMV ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
SMMV ETF Overview
Market Cap in USD | 312m |
Category | Small Blend |
TER | 0.20% |
IPO / Inception | 2016-09-07 |
SMMV ETF Ratings
Growth Rating | 57.3 |
Fundamental | - |
Dividend Rating | 56.4 |
Rel. Strength | 4.75 |
Analysts | - |
Fair Price Momentum | 40.77 USD |
Fair Price DCF | - |
SMMV Dividends
Dividend Yield 12m | 1.74% |
Yield on Cost 5y | 2.71% |
Annual Growth 5y | 9.05% |
Payout Consistency | 96.1% |
Payout Ratio | % |
SMMV Growth Ratios
Growth Correlation 3m | 70.5% |
Growth Correlation 12m | 62.4% |
Growth Correlation 5y | 60.8% |
CAGR 5y | 9.46% |
CAGR/Max DD 5y | 0.53 |
Sharpe Ratio 12m | 0.98 |
Alpha | 7.68 |
Beta | 0.602 |
Volatility | 11.49% |
Current Volume | 42.2k |
Average Volume 20d | 14k |
As of June 19, 2025, the stock is trading at USD 41.66 with a total of 42,181 shares traded.
Over the past week, the price has changed by -0.64%, over one month by -1.44%, over three months by +1.78% and over the past year by +15.56%.
Partly, yes. Based on ValueRay´s Analyses, iShares MSCI USA Small-Cap (BATS:SMMV) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 57.33 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SMMV is around 40.77 USD . This means that SMMV is currently overvalued and has a potential downside of -2.14%.
iShares MSCI USA Small-Cap has no consensus analysts rating.
According to our own proprietary Forecast Model, SMMV iShares MSCI USA Small-Cap will be worth about 45.2 in June 2026. The stock is currently trading at 41.66. This means that the stock has a potential upside of +8.4%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 45.2 | 8.4% |